THXID BRAF KIT

Somatic Gene Mutation Detection System

FDA Premarket Approval P120014 S005

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Change in the method used to determine the concentration of the oligonucleotides and probes used in the test kit.

DeviceTHXID BRAF KIT
Classification NameSomatic Gene Mutation Detection System
Generic NameSomatic Gene Mutation Detection System
ApplicantBioMerieux, Inc.
Date Received2015-05-08
Decision Date2015-06-05
PMAP120014
SupplementS005
Product CodeOWD
Advisory CommitteePathology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address bioMerieux, Inc. 595 Anglum Rd. hazelwood, MO 63042

Supplemental Filings

Supplement NumberDateSupplement Type
P120014Original Filing
S012 2021-11-23 30-day Notice
S011 2021-02-12 30-day Notice
S010 2020-01-31 30-day Notice
S009 2019-08-07 30-day Notice
S008 2017-07-03 Normal 180 Day Track
S007 2016-10-27 30-day Notice
S006 2016-01-11 Normal 180 Day Track
S005 2015-05-08 30-day Notice
S004 2015-03-03 Special (immediate Track)
S003 2015-02-24 Normal 180 Day Track
S002 2014-10-15 135 Review Track For 30-day Notice
S001 2014-10-10 135 Review Track For 30-day Notice

NIH GUDID Devices

Device IDPMASupp
03573026354909 P120014 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.